Even if the drug does not decrease the symptom burden as we hope, we will learn a lot about its effects on people with Long COVID, and if it does help, Ill be beyond thrilled. Lilly contributed the doses to the trial, which is funded by the Schmidt Initiative for Long Covid, a nonprofit organization created in 2023 by philanthropists Eric and Wendy Schmidt
[DOI] [PMC free article] [PubMed] [Google Scholar] 157.Athauda D, et al
Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis
Honesty about evidence up front: there is no registered human clinical trial of the KLOW blend itself
Injection technique, timing, and site rotation all matter
Milde tot matige gastro-intestinale bijwerkingen, waaronder misselijkheid, diarree, braken en constipatie, werden gemeld bij 67 (35%) van de 190 deelnemers in de retatrutide-groepen en 16 (35%) van de 46 deelnemers in de 1,5 mg dulaglutide-groep